HOTH THERAPEUTICS, INC.

HOTH NASDAQ
5.67
+0.07
+1.17%
Closed 16:00 08/20 EDT
Open
6.17
Prev Close
5.60
High
6.17
Low
5.30
Volume
7.78K
Avg Vol (3M)
21.22K
52 Week High
13.88
52 Week Low
3.955
% Turnover
0.08%
Market Cap
53.06M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers HOTH THERAPEUTICS, INC. HOTH stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The Company is engaged in developing and commercializing the BioLexa Platform. BioLexa Platform is a proprietary, patented antimicrobial therapy. The BioLexa Platform traps all the zinc ions by adding a chelator called DTPA, which prevents Staph biofilm formation. It intends to explore the use of the BioLexa Platform for the treatment of atopic dermatitis, or eczema. It also focuses on exploring the use of the BioLexa Platform in the aesthetic dermatology field to help treat and reduce post-procedure infections, accelerate healing and improve clinical outcomes for patients undergoing procedures.
MORE >

Recently

Name
Price
%Change